US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist
  • 0.404
  • +0.026+6.96%
Close Sep 13 16:00 ET
  • 0.395
  • -0.009-2.23%
Post 20:01 ET
3.27MMarket Cap-662P/E (TTM)

Lipella Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-40.15%-918.14K
-28.86%-1.39M
-72.03%-3.15M
-214.27%-727.71K
-115.28%-689.36K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
-112.18%-320.21K
Net income from continuing operations
39.03%-938.15K
-11.61%-1.19M
-77.81%-4.62M
-89.29%-688.88K
-85.43%-1.32M
-96.76%-1.54M
-44.70%-1.07M
-39.25%-2.6M
5.40%-363.93K
-36.06%-713.79K
Depreciation and amortization
--1.37K
--72
--1.69K
--723
--962
--0
--0
--0
--0
----
Other non cash items
---649
3,619.86%200.65K
1,160.92%121.2K
--0
----
----
233.37%5.39K
40.65%9.61K
174.29%4.7K
-3.44%1.65K
Change In working capital
-250.01%-62.03K
-170.29%-605.99K
-195.64%-9.11K
-130.98%-39.55K
128.93%213.29K
416.57%41.35K
-13.09%-224.2K
-95.18%9.52K
509.76%127.66K
-64.16%93.17K
-Change in prepaid assets
-114.76%-22.13K
-488.96%-733.6K
197.97%460.63K
243.76%104.82K
113.01%17.22K
201.78%149.98K
185.35%188.61K
-571.10%-470.18K
142.31%30.49K
-102.65%-132.33K
-Change in payables and accrued expense
55.30%-73.54K
137.08%164.04K
-192.59%-548.86K
-178.41%-165.33K
-0.92%223.44K
-222.66%-164.52K
-2,082.16%-442.46K
201.30%592.82K
419.24%210.86K
113.57%225.51K
-Change in other current assets
215.15%38
729.41%214
-518.03%-2.25K
391.18%99
-22,710.00%-2.28K
-118.44%-33
-108.44%-34
-71.43%538
-111.22%-34
-100.63%-10
-Change in other working capital
-39.91%33.6K
-223.44%-36.65K
171.59%81.37K
--20.85K
---25.1K
--55.92K
--29.69K
-264.63%-113.66K
----
----
Cash from discontinued investing activities
Operating cash flow
-40.25%-918.79K
-28.80%-1.39M
-72.03%-3.15M
-214.27%-727.71K
-115.28%-689.36K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
-112.18%-320.21K
Investing cash flow
Cash flow from continuing investing activities
-104.80%-14.43K
0
200.00%300.55K
0
0
Net PPE purchase and sale
----
----
---14.43K
----
----
----
----
--0
----
----
Net investment purchase and sale
----
----
--0
--14.43K
----
----
----
200.00%300.55K
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
-104.80%-14.43K
--0
----
----
----
200.00%300.55K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
900.00%200K
-74.49%1.34M
-69.24%1.61M
0
-250K
-25K
149.82%5.24M
233,138.20%5.24M
0
Net issuance payments of debt
--0
--0
-200.00%-275K
--0
--0
---250K
---25K
--275K
--275K
--0
Net common stock issuance
--0
--200K
--0
----
----
--0
--0
136.71%4.96M
----
----
Proceeds from stock option exercised by employees
----
----
--1.61M
----
----
----
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--0
900.00%200K
-74.49%1.34M
-69.24%1.61M
--0
---250K
---25K
149.82%5.24M
233,138.20%5.24M
--0
Net cash flow
Beginning cash position
-47.61%2.11M
-35.69%3.29M
262.26%5.12M
1,999.68%2.41M
615.81%3.11M
869.77%4.02M
262.26%5.12M
133.02%1.41M
-94.74%114.77K
-81.38%434.98K
Current changes in cash
-1.51%-918.79K
-7.75%-1.19M
-149.30%-1.83M
-82.35%883.89K
-119.79%-703.8K
-4,497.79%-905.11K
-10.36%-1.1M
359.42%3.71M
750.70%5.01M
-109.55%-320.21K
End cash Position
-61.89%1.19M
-47.61%2.11M
-35.69%3.29M
-35.69%3.29M
1,999.68%2.41M
615.81%3.11M
869.77%4.02M
262.26%5.12M
262.26%5.12M
-94.74%114.77K
Free cash flow
-40.25%-918.79K
-28.80%-1.39M
-72.82%-3.16M
-220.50%-742.14K
-115.28%-689.36K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
-112.18%-320.21K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -40.15%-918.14K-28.86%-1.39M-72.03%-3.15M-214.27%-727.71K-115.28%-689.36K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K-112.18%-320.21K
Net income from continuing operations 39.03%-938.15K-11.61%-1.19M-77.81%-4.62M-89.29%-688.88K-85.43%-1.32M-96.76%-1.54M-44.70%-1.07M-39.25%-2.6M5.40%-363.93K-36.06%-713.79K
Depreciation and amortization --1.37K--72--1.69K--723--962--0--0--0--0----
Other non cash items ---6493,619.86%200.65K1,160.92%121.2K--0--------233.37%5.39K40.65%9.61K174.29%4.7K-3.44%1.65K
Change In working capital -250.01%-62.03K-170.29%-605.99K-195.64%-9.11K-130.98%-39.55K128.93%213.29K416.57%41.35K-13.09%-224.2K-95.18%9.52K509.76%127.66K-64.16%93.17K
-Change in prepaid assets -114.76%-22.13K-488.96%-733.6K197.97%460.63K243.76%104.82K113.01%17.22K201.78%149.98K185.35%188.61K-571.10%-470.18K142.31%30.49K-102.65%-132.33K
-Change in payables and accrued expense 55.30%-73.54K137.08%164.04K-192.59%-548.86K-178.41%-165.33K-0.92%223.44K-222.66%-164.52K-2,082.16%-442.46K201.30%592.82K419.24%210.86K113.57%225.51K
-Change in other current assets 215.15%38729.41%214-518.03%-2.25K391.18%99-22,710.00%-2.28K-118.44%-33-108.44%-34-71.43%538-111.22%-34-100.63%-10
-Change in other working capital -39.91%33.6K-223.44%-36.65K171.59%81.37K--20.85K---25.1K--55.92K--29.69K-264.63%-113.66K--------
Cash from discontinued investing activities
Operating cash flow -40.25%-918.79K-28.80%-1.39M-72.03%-3.15M-214.27%-727.71K-115.28%-689.36K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K-112.18%-320.21K
Investing cash flow
Cash flow from continuing investing activities -104.80%-14.43K0200.00%300.55K00
Net PPE purchase and sale -----------14.43K------------------0--------
Net investment purchase and sale ----------0--14.43K------------200.00%300.55K--0--0
Cash from discontinued investing activities
Investing cash flow ---------104.80%-14.43K--0------------200.00%300.55K--0--0
Financing cash flow
Cash flow from continuing financing activities 0900.00%200K-74.49%1.34M-69.24%1.61M0-250K-25K149.82%5.24M233,138.20%5.24M0
Net issuance payments of debt --0--0-200.00%-275K--0--0---250K---25K--275K--275K--0
Net common stock issuance --0--200K--0----------0--0136.71%4.96M--------
Proceeds from stock option exercised by employees ----------1.61M------------------0--------
Cash from discontinued financing activities
Financing cash flow --0900.00%200K-74.49%1.34M-69.24%1.61M--0---250K---25K149.82%5.24M233,138.20%5.24M--0
Net cash flow
Beginning cash position -47.61%2.11M-35.69%3.29M262.26%5.12M1,999.68%2.41M615.81%3.11M869.77%4.02M262.26%5.12M133.02%1.41M-94.74%114.77K-81.38%434.98K
Current changes in cash -1.51%-918.79K-7.75%-1.19M-149.30%-1.83M-82.35%883.89K-119.79%-703.8K-4,497.79%-905.11K-10.36%-1.1M359.42%3.71M750.70%5.01M-109.55%-320.21K
End cash Position -61.89%1.19M-47.61%2.11M-35.69%3.29M-35.69%3.29M1,999.68%2.41M615.81%3.11M869.77%4.02M262.26%5.12M262.26%5.12M-94.74%114.77K
Free cash flow -40.25%-918.79K-28.80%-1.39M-72.82%-3.16M-220.50%-742.14K-115.28%-689.36K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K-112.18%-320.21K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data